newsfilter
← Latest News
GlobeNewswire·

Optimi Health Receives Certificate of Analysis For MDMA 40mg and 60mg GMP Capsules

VANCOUVER, British Columbia, May 14, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) (FRA: 8BN), a leading Health Canada-licensed GMP psychedelics pharmaceutical manufacturer specializing in